F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
How to ensure optimal treatment for patients with residual disease
Date
14 Sep 2020Session
F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBCPresenters
Andrew WardleyAuthors
A.M. WardleyAuthor affiliations
- The Nihr Manchester Clinical Research Facility At The Christie, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB
Resources
Resources from the same session
Welcome and Introduction: Evolution of patient care in HER2-positive eBC
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Continuing a patient's journey after pCR: Evidence-based decision–making
Presenter: Christian Jackisch
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Going beyond medicine in HER2-positive breast cancer
Presenter: Christian Jackisch
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Panel discussion
Presenter: Andrew Wardley
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Summary and close
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast